Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.900
+0.080 (2.09%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Cytek Biosciences Employees
Cytek Biosciences had 648 employees as of December 31, 2024. The number of employees decreased by 28 or -4.14% compared to the previous year.
Employees
648
Change (1Y)
-28
Growth (1Y)
-4.14%
Revenue / Employee
$302,523
Profits / Employee
-$9,880
Market Cap
496.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 648 | -28 | -4.14% |
| Dec 31, 2023 | 676 | 93 | 15.95% |
| Dec 31, 2022 | 583 | 81 | 16.14% |
| Dec 31, 2021 | 502 | 111 | 28.39% |
| Dec 31, 2020 | 391 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CTKB News
- 2 days ago - Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry - GlobeNewsWire
- 9 days ago - Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 16 days ago - Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth - GlobeNewsWire
- 6 weeks ago - Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control - Business Wire
- 7 weeks ago - Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA - GlobeNewsWire
- 7 weeks ago - Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript - Seeking Alpha